ADDPHARMA

addpharma-logo

AddPharma develops new drugs, established by the gathering of key personnel who have successfully developed new drugs for many companies for decades. Adpharma is accelerating the development of new and improved drugs based on its long-established technology for complexes, release control agents, and absorption improvers.

#SimilarOrganizations #Website #More

ADDPHARMA

Founded:
2017-01-01

Address:
Giheung, Kyonggi-do, South Korea

Country:
South Korea

Website Url:
http://www.addpharma.co.kr

Total Employee:
51+

Status:
Active

Technology used in webpage:
Euro SSL By Default Nginx CrUX Top 50m CrUX Dataset Sectigo SSL Sectigo Domain SSL Korea Telecom


Similar Organizations

avenzoar-pharmaceuticals-logo

Avenzoar Pharmaceuticals

Avenzoar Pharmaceuticals is a pharmaceutical company developing cancer drugs.

generos-biopharma-logo

GenEros Biopharma

GenEros Biopharma is a biopharmaceutical company that develops autoimmune and anti-inflammation therapeutics.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

mankind-pharma-logo

Mankind Pharma

Mankind Pharma is a pharmaceutical company that develops, commercializes, and delivers medicines for urgent medical needs.

smartnuclide-logo

SmartNuclide

SmartNuclide is a biopharmaceutical company that develops biological drug products.

takeda-logo

Takeda

Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.

teva-pharmaceutical-industries-logo

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.

vc-cell-therapy-logo

VC Cell Therapy

VC Cell Therapy is a pharmaceutical company that provides regenerative medicines.

Official Site Inspections

http://www.addpharma.co.kr Semrush global rank: 14.06 M Semrush visits lastest month: 63

  • Host name: mail210.webmaker21.kr
  • IP address: 115.68.17.210
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Addpharma"

Addpharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Nov 1, 2024 www.addpharma.co.kr. Private Company | 2017 | Gyeonggi-do, South Korea | 50-100 | www.addpharma.co.kr. Last update 01 Nov 2024. Overview. Pipeline. Deal. โ€ฆSee details»

Addpharma - Crunchbase Company Profile & Funding

AddPharma develops new drugs, established by the gathering of key personnel who have successfully developed new drugs for many companies for โ€ฆSee details»

www.addpharma.co.kr

J:ล’ÔHMs;ÿßtökù û7ลพb8ÁÈ6¤ฦ’§ L) #l ลก86ãBòÛb·โ„ข¿Ó»ºÖÐ ï/1«Cโ€\L#ล v±85EoÌt ôÈล“þýZ¥; ¹ 22 aห†m"tTtêÁÿ©îลพโ„ขª ªê9Üå¹ uxñý×0xÀ $ .J@ù8ฦ’ÂÜkX6¹6Ûwß&ล โ‚ฌล  ¸ÏíLÏS *©Ç7โ€“²ฦ’ UM$ þX โ€  โ€ฆSee details»

Addpharma Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Addpharma Inc. of Yongin, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»

Organization | Addpharma Inc.

Addpharma Inc. Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: Seoul Korea, Republic of (2017 ... Organization Overview. First Clinical Trial. 2018 NCT03586037. First โ€ฆSee details»

Addpharma | VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

Addpharma, Inc.: Drug pipelines, Patents, Clinical trials - Synapse

|www.addpharma.co.kr. Last update 02 Aug 2023See details»

Found - addpharma.co.kr

์• ๋“œํŒŒ๋งˆใˆœ์˜ ์œ„์น˜ ์ •๋ณด๋ฅผ ์ œ๊ณตํ•˜๋Š” ์›นํŽ˜์ด์ง€์ž…๋‹ˆ๋‹ค.See details»

Found - addpharma.co.kr

Found. The document has moved here.See details»

AD-211 - Drug Targets, Indications, Patents - Synapse - Patsnap

Nov 21, 2024 AD-211, Initially developed by Addpharma, Inc., Now, its global highest R&D status is Phase 1, Therapeutic Areas: Nervous System Diseases, Active Indication: Pain ...See details»

Addpharma Company Profile 2024: Valuation, Funding & Investors โ€ฆ

Addpharma General Information Description. Operator of an online pharmacy intended to help people on their path to improved health. The company's pharmacy offers a range of healthcare โ€ฆSee details»

Addpharma - Overview, News & Similar companies | ZoomInfo.com

Addpharma Inc is a company that operates in the Electrical/Electronic Manufacturing industry. It employs 21-50 people and has $5M-$10M of revenue. ... South Korea. Website. โ€ฆSee details»

AD-104 - Drug Targets, Indications, Patents - Synapse - Patsnap

Nov 21, 2024 Addpharma, Inc. KCT0009332 / Completed Phase 1 An open label, randomized, single dose, 2-sequence, 2-period, cross-over phase 1 study to evaluate the safety and โ€ฆSee details»

AD-227A and AD-227B and AD-227C in Essential Hypertension

May 29, 2024 A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B July 30, 2024 updated by: Addpharma Inc. A Multicenter, Randomized, Double โ€ฆSee details»

AD 202 - AdisInsight - Springer

Feb 1, 2023 If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโ€™s network Login with username/password โ€ฆSee details»

AD-201 - Drug Targets, Indications, Patents - Synapse - Patsnap

An open-label, randomized, 2-sequence, 4-period, sinlge-dose, repeated-crossover study to evaluate the pharmacokinetics and the safety of AD-201 compared to coadministration of AD โ€ฆSee details»

Home 1 - AddPharma | Pharmacy in Ghana

Visited @addpharma today and their services was awesome. I strongly recommend Addpharma to everyone. Very affordable pricing and excellent customer service. Alexander Ashitey August โ€ฆSee details»

Addpharma - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

AD 110 - AdisInsight

If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโ€™s network Login with username/password or try to โ€ฆSee details»

AD 203 - AdisInsight - Springer

If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโ€™s network Login with username/password or try to โ€ฆSee details»

linkstock.net © 2022. All rights reserved